Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $46.9950 (-2.03%) ($46.9950 - $46.9950) on Tue. Mar. 16, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.25% (three month average) | RSI | 55 | Latest Price | $46.9950(-2.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 0.7% a day on average for past five trading days. | Weekly Trend | TGTX advances 4.9% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(68%) ARKG(64%) ARKK(59%) IBB(59%) IWO(59%) | Factors Impacting TGTX price | TGTX will decline at least -1.625% in a week (0% probabilities). VIXM(-41%) VXX(-36%) UUP(-19%) UNG(-2%) TLT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.625% (StdDev 3.25%) | Hourly BBV | -1.9 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $48.37(-2.84%) | 10 Day Moving Average | $45.83(2.54%) | 20 Day Moving Average | $45.43(3.44%) | To recent high | -14.1% | To recent low | 12.8% | Market Cap | $5.952b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |